Myongji Hospital
Endovenous radiofrequence ablation (EVRF) in the Republic of Korea typically costs from AUD $3,300 to AUD $5,400. Total expenses depend on the number of legs treated and the clinic tier. In Australia, this procedure averages AUD $4,400. Patients can save approximately 26% by choosing Korean medical centres. Prices generally cover the surgical procedure, local anaesthesia, and initial post-operative follow-up.
Bookimed Expert Insight: Australian patients find value in Korea's multidisciplinary general hospitals. For example, Myongji Hospital in Goyang treats 600,000 patients annually. They operate an International Healthcare Center specifically for overseas coordination. This ensures smooth interpretation and treatment support. Specialists like Dr. Oh Dongju bring international expertise to Korean clinics. He served as a Governor for the American College of Cardiology (ACC). This high level of specialization provides peace of mind for cardiac-related vascular care.
| Republic of Korea | Thailand | Turkey | |
| Endovenous radiofrequence ablation (EVRF) | ≈ AUD $3,300 | ≈ AUD $2,600 | from AUD $2,700 |
No hidden fees – just official clinic prices. Pay at the clinic for Endovenous radiofrequence ablation (EVRF) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Endovenous radiofrequence ablation (EVRF) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Endovenous radiofrequence ablation (EVRF) journey.
Dr. Oh Dongju, MD, PhD, is a cardiologist. He specializes in hypertension, hyperlipidemia, angina, myocardial infarction, valvular disease, dilated cardiomyopathy, and myocarditis. His work also covers atherosclerosis and arterial occlusive disease. He is skilled in echocardiography and cardiovascular imaging.
He completed a cardiology fellowship at Emory University School of Medicine. He also served as a Clinical Instructor at the Cornell University Weill Department of Medicine. He has held many leadership roles. He served as President, KSIC; Director of Publications, General Affairs, and Public Relations, KSC; Chairman, KACG; Board Member, Asan Heart Foundation; Vice President, KHA; Chairman, Division of Cardiology, KAIM; Vice President, NAMOK/KAMS; Governor, ACC Korea Chapter; and Member, the National Bioethics Committee.